Activity Description
In this video, Damon Dierker, OD, FAAO provides an overview of ocular surface disease (OSD) and discusses OSD management options, including over-the-counter, prescription topical and nasal neurostimulation. A case illustrates a custom approach to treatment.
Accreditation
Sponsored by
The Fundingsland Group, LLC is a COPE-Approved Administrator.
This activity, COPE Activity Number 130238, is accredited by COPE for continuing education for optometrists. This course is approved for .25 hours of CE.
Course # 96650-TD
Activity #: 130238
COPE advises optometrists to contact the State or Provincial Board where they are licensed for verification of what is acceptable for license renewal.
Release Date: 03-31-2025
Expiration Date: 03-31-2026
Grant Support Statement
This activity is supported by unrestricted educational grants from Apellis Pharmaceuticals, Inc., LENZ Therapeutics, Orasis Pharmaceuticals,Tarsus Pharmaceuticals, Inc., Topcon Healthcare, Inc., and Viatris, Inc.
Faculty
